Загрузка...
Comparative efficacy of indacaterol in chronic obstructive pulmonary disease
Long-acting bronchodilators have been shown to improve multiple clinical outcomes in chronic obstructive pulmonary disease (COPD) including lung function, symptoms, dyspnea, quality of life, and exacerbations. Indacaterol is a novel, inhaled, long-acting β2-agonist providing 24-hour bronchodilation...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3299544/ https://ncbi.nlm.nih.gov/pubmed/22419862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S19805 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|